Given the marked up-regulation of CDKL3 in CCA, and the strong anticancer effect of curcumol on CCA cells, we speculate that CDKL3 may be a potential therapeutic target for CCA, and in this aspect, curcumol may be a promising anticancer agent. The gene discussed is CDKL3; the disease is cholangiocarcinoma.